Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 332

    1.

    Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.

    Dunn FL, Pietri A, Raskin P.

    Ann Intern Med. 1981 Oct;95(4):426-31.PMID: 7025720 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.

    Guerci B, Igau B, Ziegler O, Crea T, Fruchart JC, Drouin P, Fievet C.

    Metabolism. 1996 Apr;45(4):430-4.PMID: 8609827 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.

    Bagdade JD, Helve E, Taskinen MR.

    Metabolism. 1991 May;40(5):445-9.PMID: 2023530 [PubMed - indexed for MEDLINE]Related articles

    5.
    6.

    Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump.

    Falko JM, O'Dorisio TM, Cataland S.

    JAMA. 1982 Jan 1;247(1):37-9.PMID: 7031287 [PubMed - indexed for MEDLINE]Related articles

    7.

    Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.

    Ruotolo G, Parlavecchia M, Taskinen MR, Galimberti G, Zoppo A, Le NA, Ragogna F, Micossi P, Pozza G.

    Diabetes Care. 1994 Jan;17(1):6-12.PMID: 8112191 [PubMed - indexed for MEDLINE]Related articles

    8.

    Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.

    Tamborlane WV, Sherwin RS, Genel M, Felig P.

    Am J Med. 1980 Feb;68(2):190-6.PMID: 6986766 [PubMed - indexed for MEDLINE]Related articles

    9.

    Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients.

    Møller A, Rasmussen L, Ledet T, Christiansen JS, Christensen CK, Mogensen CE, Hermansen K.

    Scand J Clin Lab Invest. 1986 Sep;46(5):471-5.PMID: 3529352 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serum lipid and lipoprotein levels and metabolic control in insulin-treated diabetics.

    Fedele D, Fellin R, Lapolla A, Baggio G, De Romedi F, Frigato F, Crepaldi G.

    Acta Diabetol Lat. 1982 Apr-Jun;19(2):151-9.PMID: 7051712 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients.

    Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH.

    N Engl J Med. 1980 Mar 20;302(12):650-4.PMID: 6986551 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.

    Goldberg RB, Reeves ML, Seigler DE, Ryan EA, Miller N, Hsia SL, Skyler JS.

    Acta Diabetol Lat. 1985 Apr-Jun;22(2):93-101.PMID: 3907233 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.

    Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS.

    Arch Intern Med. 1998 Dec 7-21;158(22):2485-90.PMID: 9855387 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effect of continuous subcutaneous insulin infusion on serum lipids.

    Lawson P, Trayner I, Rosenstock J, Kohner E.

    Diabete Metab. 1984 Oct;10(4):239-44.PMID: 6510544 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients]

    Schernthaner G, Graninger W, Kwasny W, Prager R, Otto C.

    Acta Med Austriaca. 1982;9(5-6):205-13. German. PMID: 6762034 [PubMed - indexed for MEDLINE]Related articles

    16.

    Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.

    Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA.

    Diabetologia. 1982 Jun;22(6):430-6.PMID: 7049800 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

    Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

    Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667. PMID: 11478431 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reduction in cardiovascular risk factors with intensive diabetes treatment in insulin-dependent diabetes mellitus.

    Rosenstock J, Strowig S, Cercone S, Raskin P.

    Diabetes Care. 1987 Nov-Dec;10(6):729-34.PMID: 3322730 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Plasma lipid pattern in diabetics before and after insulin treatment: total lipids, triglycerides, phospholipids, and -lipoprotein cholesterol and single NEFA (C 16 -C 18 )]

    Bertolini AM, Santagostino A.

    Acta Diabetol Lat. 1972 May-Jun;9(3):358-72. Multiple languages. No abstract available. PMID: 4654330 [PubMed - indexed for MEDLINE]Related articles

    20.

    Diabetic dyslipidemia.

    Kreisberg RA.

    Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.PMID: 9915665 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data